Logo image of CTRN

CITI TRENDS INC (CTRN) Stock Fundamental Analysis

USA - NASDAQ:CTRN - US17306X1028 - Common Stock

33.93 USD
+0.16 (+0.47%)
Last: 9/12/2025, 8:00:01 PM
33.93 USD
0 (0%)
After Hours: 9/12/2025, 8:00:01 PM
Fundamental Rating

3

CTRN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 123 industry peers in the Specialty Retail industry. CTRN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CTRN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CTRN had negative earnings in the past year.
CTRN had a positive operating cash flow in the past year.
In multiple years CTRN reported negative net income over the last 5 years.
In multiple years CTRN reported negative operating cash flow during the last 5 years.
CTRN Yearly Net Income VS EBIT VS OCF VS FCFCTRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

With a Return On Assets value of -8.89%, CTRN is not doing good in the industry: 73.98% of the companies in the same industry are doing better.
With a Return On Equity value of -35.81%, CTRN is not doing good in the industry: 65.85% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.89%
ROE -35.81%
ROIC N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-3.45%
ROE(5y)11.58%
ROIC(3y)N/A
ROIC(5y)N/A
CTRN Yearly ROA, ROE, ROICCTRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

CTRN's Gross Margin of 37.71% is in line compared to the rest of the industry. CTRN outperforms 55.28% of its industry peers.
In the last couple of years the Gross Margin of CTRN has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for CTRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.05%
GM growth 5Y-0.3%
CTRN Yearly Profit, Operating, Gross MarginsCTRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

CTRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CTRN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CTRN has been reduced compared to 5 years ago.
There is no outstanding debt for CTRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CTRN Yearly Shares OutstandingCTRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CTRN Yearly Total Debt VS Total AssetsCTRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 2.98 indicates that CTRN is not a great score, but indicates only limited risk for bankruptcy at the moment.
CTRN has a Altman-Z score of 2.98. This is in the better half of the industry: CTRN outperforms 65.85% of its industry peers.
There is no outstanding debt for CTRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.98
ROIC/WACCN/A
WACC9.5%
CTRN Yearly LT Debt VS Equity VS FCFCTRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

CTRN has a Current Ratio of 1.12. This is a normal value and indicates that CTRN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.12, CTRN is not doing good in the industry: 68.29% of the companies in the same industry are doing better.
A Quick Ratio of 0.39 indicates that CTRN may have some problems paying its short term obligations.
The Quick ratio of CTRN (0.39) is worse than 62.60% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.39
CTRN Yearly Current Assets VS Current LiabilitesCTRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for CTRN have decreased strongly by -29.69% in the last year.
The Revenue has been growing slightly by 0.69% in the past year.
Measured over the past years, CTRN shows a decrease in Revenue. The Revenue has been decreasing by -0.75% on average per year.
EPS 1Y (TTM)-29.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.73%
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-8.76%
Revenue growth 5Y-0.75%
Sales Q2Q%8.04%

3.2 Future

CTRN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.07% yearly.
Based on estimates for the next years, CTRN will show a small growth in Revenue. The Revenue will grow by 5.80% on average per year.
EPS Next Y73.05%
EPS Next 2Y47.36%
EPS Next 3Y33.26%
EPS Next 5Y24.07%
Revenue Next Year5.64%
Revenue Next 2Y5.29%
Revenue Next 3Y5.75%
Revenue Next 5Y5.8%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CTRN Yearly Revenue VS EstimatesCTRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CTRN Yearly EPS VS EstimatesCTRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CTRN. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 43.20 indicates a quite expensive valuation of CTRN.
CTRN's Price/Forward Earnings is on the same level as the industry average.
CTRN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.73.
Industry RankSector Rank
PE N/A
Fwd PE 43.2
CTRN Price Earnings VS Forward Price EarningsCTRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CTRN Per share dataCTRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTRN's earnings are expected to grow with 33.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.36%
EPS Next 3Y33.26%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CTRN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CITI TRENDS INC

NASDAQ:CTRN (9/12/2025, 8:00:01 PM)

After market: 33.93 0 (0%)

33.93

+0.16 (+0.47%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-26 2025-08-26/bmo
Earnings (Next)12-01 2025-12-01/bmo
Inst Owners94.4%
Inst Owner Change-42.84%
Ins Owners10.86%
Ins Owner Change1.01%
Market Cap281.96M
Analysts82.5
Price Target48.96 (44.3%)
Short Float %5.42%
Short Ratio5.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-376.65%
Min EPS beat(2)-938.78%
Max EPS beat(2)185.47%
EPS beat(4)1
Avg EPS beat(4)-258.15%
Min EPS beat(4)-938.78%
Max EPS beat(4)185.47%
EPS beat(8)2
Avg EPS beat(8)-156.03%
EPS beat(12)4
Avg EPS beat(12)-105.71%
EPS beat(16)8
Avg EPS beat(16)-56.54%
Revenue beat(2)1
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-2.13%
Max Revenue beat(2)0.95%
Revenue beat(4)1
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-3.37%
Max Revenue beat(4)0.95%
Revenue beat(8)2
Avg Revenue beat(8)-1.87%
Revenue beat(12)3
Avg Revenue beat(12)-2.19%
Revenue beat(16)6
Avg Revenue beat(16)-1.66%
PT rev (1m)24.68%
PT rev (3m)57.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.76%
Revenue NY rev (1m)0.95%
Revenue NY rev (3m)1.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 43.2
P/S 0.37
P/FCF N/A
P/OCF 58.79
P/B 2.6
P/tB 2.6
EV/EBITDA N/A
EPS(TTM)-2.97
EYN/A
EPS(NY)0.79
Fwd EY2.31%
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)0.58
OCFY1.7%
SpS92.48
BVpS13.06
TBVpS13.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.89%
ROE -35.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.71%
FCFM N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-3.45%
ROE(5y)11.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.05%
GM growth 5Y-0.3%
F-Score4
Asset Turnover1.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.73%
Cap/Sales 1.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.39
Altman-Z 2.98
F-Score4
WACC9.5%
ROIC/WACCN/A
Cap/Depr(3y)80.1%
Cap/Depr(5y)94.79%
Cap/Sales(3y)2.05%
Cap/Sales(5y)2.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.73%
EPS Next Y73.05%
EPS Next 2Y47.36%
EPS Next 3Y33.26%
EPS Next 5Y24.07%
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-8.76%
Revenue growth 5Y-0.75%
Sales Q2Q%8.04%
Revenue Next Year5.64%
Revenue Next 2Y5.29%
Revenue Next 3Y5.75%
Revenue Next 5Y5.8%
EBIT growth 1Y-85.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year121.37%
EBIT Next 3Y45.71%
EBIT Next 5Y30.92%
FCF growth 1Y-57.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.66%
OCF growth 3YN/A
OCF growth 5YN/A